MCHX
Marchex, Inc.
MCHX's outlook is improving, though it still trails on the overall score.
META
Meta Platforms, Inc.
META has the edge over MCHX overall, supported by stronger fundamentals and stronger valuation.
MCHX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Strong |
MCHX's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
MCHX PE Valuation
MCHX has no meaningful PE right now: it lost money over the past year.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
MCHX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
MCHX has the edge over META on the outlook, with more favorable profitability expectations.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
MCHX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.15 | — |
| Q2 2026 | -$0.12 | -$0.02 |
| Q1 2026 | -$0.11 | +$0.01 |
| Q4 2025 | -$0.11 | $0.00 |
| Q3 2025 | -$0.10 | -$0.01 |
| Q2 2025 | -$0.10 | +$0.01 |
| Q1 2025 | -$0.12 | +$0.03 |
| Q4 2024 | -$0.11 | +$0.11 |
| Q3 2022 | -$0.14 | +$0.02 |
MCHX is still losing money, but less than at its worst: $0.12 per share over the past year, against $0.22 at its worst in late 2023.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META has the edge over MCHX on earnings quality, reporting a profit while its opponent remains loss making.
MCHX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11M | -5.6% |
| Q1 2026 | $10.6M | -6.9% |
| Q4 2025 | $10.8M | -9% |
| Q3 2025 | $11.5M | -8.3% |
| Q2 2025 | $11.7M | -3.5% |
| Q1 2025 | $11.4M | -1.5% |
| Q4 2024 | $11.9M | -3.8% |
| Q3 2024 | $12.6M | -1.8% |
MCHX's revenue has slid since its 2019 peak: $11M last quarter, down 5.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -3.1% | +1.5 points |
| Q1 2026 | -13% | +3.7 points |
| Q4 2025 | -22% | -8.6 points |
| Q3 2025 | -8.2% | -1.6 points |
| Q2 2025 | -4.6% | +1.4 points |
| Q1 2025 | -16% | -5.1 points |
| Q4 2024 | -13% | -4.3 points |
| Q3 2024 | -6.6% | +3.8 points |
MCHX's operating margin was −3.1% last quarter, up 1.5 points from the same quarter a year ago, near the top of its range since 2019.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over MCHX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META has the edge over MCHX on profitability, with a higher operating margin.
MCHX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$651K | -243% |
| Q1 2026 | -$957K | +$2M |
| Q4 2025 | $116K | -84% |
| Q3 2025 | $897K | +351% |
| Q2 2025 | $454K | +1035% |
| Q1 2025 | -$2.9M | -$429K |
| Q4 2024 | $710K | -21% |
| Q3 2024 | $199K | +$579K |
MCHX has burned cash in most quarters: −$595,000 over the past year, against −$2M the year before.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META has the edge over MCHX on cash generation, producing positive trailing cash flow while its opponent burns cash.
MCHX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +13% | +5.5M shares |
| 1 year | 0% | -- |
| 3 years | +3% | +1.4M shares |
| 5 years | +0.1% | +70K shares |
| Available history | -3.5% | -1.7M shares |
MCHX has 49M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has 2.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
MCHX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | -10.9x | Net Cash |
| Q1 2022 | -5.4x | Net Cash |
| Q4 2021 | -27.6x | Net Cash |
| Q4 2019 | -28.7x | Net Cash |
| Q3 2019 | -23.5x | Net Cash |
MCHX has more cash than debt.
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META's net debt is less than a year of its operating earnings (EBITDA).
MCHX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.7 | Neutral |
| Stochastic | 26.9 | Neutral |
MCHX's weekly RSI is 44 (neutral) and its Stochastic is 27 (neutral).
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
MCHX PE vs Communication Services Sector
MCHX has no meaningful PE right now: it lost money over the past year.
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.
MCHX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.32 | 4.5% above |
| 20 week MA | $1.55 | 11% below |
| 50 week MA | $1.58 | 13% below |
| 100 week MA | $1.71 | 19% below |
| 200 week MA | $1.69 | 18% below |
MCHX has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 18% below its 200-week average.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has fallen below most of its moving averages, though it's still 21% above its 200-week average.
MCHX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.77 | $2.15 | -43% |
| 2021 | $2.15 | $2.71 | +26% |
| 2022 | $2.71 | $1.71 | -37% |
| 2023 | $1.71 | $1.36 | -20% |
| 2024 | $1.36 | $1.88 | +38% |
| 2025 | $1.88 | $1.67 | -11% |
| 2026 YTD | $1.67 | $1.38 | -17% |
MCHX has finished lower in four of the last six years. It's down 17% so far in 2026.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META has the edge over MCHX on returns for 2026, with the stronger performance.